Sarcoma & GIST
Turalio is the first therapy approved for the rare joint tumor and is available only through the Turalio Risk Evaluation and Mitigation (REMS)...
From the Journals
After implementation of the default order specifying no daily imaging during palliative radiation therapy, patients were 63% less likely to...
Nearly a quarter of the patients screened as part of the National Cancer Institute–Children’s Oncology Group Pediatric MATCH trial have been...
Entrectinib produced responses in patients who had fusions or mutations in target genes.